Interview with Dr. Cristoph Correll

What are the most important trends in CNS clinical trials? What lies ahead in 2019 and beyond?

Christoph U. Correll, MD, a member of WCG’s Scientific Leadership Team, shared his thoughts in a recent conversation with Mark Opler, MD, PhD, chief research officer at WCG-MedAvante-ProPhase. Dr. Correll is both a clinical psychiatrist (for both adults and children) and a clinical scientist. His work focuses on the identification, characterization and treatment of adults and youths with severe psychiatric disorders. His particular area of expertise is psychopharmacology.

Previous Flipbook
Trend: Genetic Testing and Data Privacy Ownership
Trend: Genetic Testing and Data Privacy Ownership

Next Flipbook
Solving the Problem of Clinical Research Enrollment
Solving the Problem of Clinical Research Enrollment

Benchmark your study enrollment versus competitors

Get Benchmark Data